Tennessee Oncology Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Tennessee Oncology's estimated annual revenue is currently $342.8M per year.(i)
  • Tennessee Oncology's estimated revenue per employee is $378,000

Employee Data

  • Tennessee Oncology has 907 Employees.(i)
  • Tennessee Oncology grew their employee count by 7% last year.

Tennessee Oncology's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
COOReveal Email/Phone
3
CFOReveal Email/Phone
4
SVP Pharmacy ServicesReveal Email/Phone
5
SVP PharmacyReveal Email/Phone
6
SVP Radiation Oncology ServicesReveal Email/Phone
7
Director Education ServicesReveal Email/Phone
8
Director Pharmacy ServicesReveal Email/Phone
9
Executive Director, Nursing ServicesReveal Email/Phone
10
Director Marketing and Physician ServicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.2M751%N/AN/A
#2
$938.2M24829%N/AN/A
#3
$8.9M413%N/AN/A
#4
$112.4M333N/AN/AN/A
#5
$17.5M7216%N/AN/A
#6
$1067.9M28253%N/AN/A
#7
$22.4M838%N/AN/A
#8
$266.1M704-4%N/AN/A
#9
$112.4M3333%N/AN/A
#10
$61.8M208-1%N/AN/A
Add Company

What Is Tennessee Oncology?

Tennessee Oncology, PLLC is committed to leadership and excellence in oncology care. We believe that each patient deserves the highest quality of care that our practice has to offer. We are dedicated to delivering excellence of care. We are committed to clinical research and innovative treatment protocols in order to increase our patients' chances for better outcomes. We recognize families are an integral part of patients' lives and vital to their well-being so we are committed to providing education and emotional support for the family unit.

keywords:N/A

N/A

Total Funding

907

Number of Employees

$342.8M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Tennessee Oncology News

2022-04-20 - In Charge 2022: Health Care | Leaders 2022 | nashvillepost.com

Jeff Patton — President and CEO, OneOncology: Longtime leader of Tennessee Oncology who in 2020 took over from Tracy Bahl.

2022-04-19 - First Patient Treated in Study to Determine Tolerability, Dosing of ...

... Benjamin Garmezy, assistant director of Genitourinary Research for Sarah Cannon Research Institute at Tennessee Oncology in Nashville.

2022-04-06 - Dr Stephen Schleicher on Future Advances in Value-Based Care

Stephen Schleicher, MD, MBA, chief medical officer of Tennessee Oncology, talks about lessons learned from the Oncology Care Model (OCM) and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$343.6M909-2%N/A
#2
$231.8M920N/AN/A
#3
$75M923-4%N/A
#4
$238.6M947N/AN/A
#5
$75M949-1%N/A